Free Trial

Precigen (PGEN) Short Interest Ratio & Short Volume

→ **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad)
Free PGEN Stock Alerts
$1.38
0.00 (0.00%)
(As of 03:03 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Precigen Short Interest Data

Current Short Interest
15,210,000 shares
Previous Short Interest
15,960,000 shares
Change Vs. Previous Month
-4.70%
Dollar Volume Sold Short
$20.08 million
Short Interest Ratio
16.0 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
252,420,000 shares
Float Size
128,830,000 shares
Short Percent of Float
11.81%
Today's Trading Volume
260,157 shares
Average Trading Volume
990,779 shares
Today's Volume Vs. Average
26%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Precigen ?

Sign up to receive the latest short interest report for Precigen and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

PGEN Short Interest Over Time

PGEN Days to Cover Over Time

PGEN Percentage of Float Shorted Over Time

Precigen Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202415,210,000 shares $20.08 million -4.7%11.8%16 $1.32
4/15/202415,960,000 shares $22.34 million -5.6%13.0%15.8 $1.40
3/31/202416,900,000 shares $24.51 million -0.1%13.7%15.8 $1.45
3/15/202416,910,000 shares $24.18 million -2.1%13.7%14.3 $1.43
2/29/202417,270,000 shares $26.60 million -1.5%13.8%14.5 $1.54
2/15/202417,540,000 shares $25.08 million -6.3%14.0%15.1 $1.43
1/31/202418,710,000 shares $25.82 million -0.7%15.0%13.4 $1.38
1/15/202418,840,000 shares $25.81 million +4.7%15.1%13.2 $1.37
12/31/202317,990,000 shares $24.11 million +2.3%14.4%12.9 $1.34
12/15/202317,590,000 shares $21.46 million -3.1%14.1%13.2 $1.22
11/30/202318,150,000 shares $20.33 million +11.7%14.2%14.1 $1.12
11/15/202316,250,000 shares $17.23 million +2.3%12.7%11.6 $1.06
10/31/202315,880,000 shares $17.94 million +4.3%12.1%10.5 $1.13
10/15/202315,220,000 shares $18.26 million +1.7%11.6%10.1 $1.20
9/30/202314,970,000 shares $21.26 million -3.0%12.4%9.6 $1.42
9/15/202315,430,000 shares $22.99 million +12.7%12.8%9.8 $1.49
8/31/202313,690,000 shares $23.96 million +39.4%11.4%8.2 $1.75
8/15/20239,820,000 shares $15.02 million +13.1%8.2%6.1 $1.53
7/31/20238,680,000 shares $12.07 million -9.6%6.6%7 $1.39
7/15/20239,600,000 shares $11.33 million -3.0%7.3%7.9 $1.18
6/30/20239,900,000 shares $11.39 million +1.0%7.5%8.3 $1.15
6/15/20239,800,000 shares $12.45 million -8.9%7.4%7.1 $1.27
5/31/202310,760,000 shares $12.80 million -0.7%8.3%7.7 $1.19
5/15/202310,840,000 shares $13.12 million -3.9%8.3%7.2 $1.21
4/30/202311,280,000 shares $13.65 million -9.2%8.7%6.4 $1.21
4/15/202312,420,000 shares $13.04 million +0.3%9.6%5.3 $1.05
3/31/202312,380,000 shares $13.12 million +5.6%9.6%5.4 $1.06
3/15/202311,720,000 shares $12.89 million +5.7%9.1%5.6 $1.10
2/28/202311,090,000 shares $13.97 million +36.6%8.6%6 $1.26
2/15/20238,120,000 shares $12.26 million +1.3%6.3%4.7 $1.51
1/31/20238,020,000 shares $12.99 million +24.0%6.2%5.4 $1.62
1/15/20236,470,000 shares $13.00 million -4.7%6.6%6.4 $2.01
12/30/20226,790,000 shares $10.32 million +1.3%6.9%9.5 $1.52
12/15/20226,700,000 shares $10.99 million -5.0%6.8%9 $1.64
11/30/20227,050,000 shares $12.83 million -5.9%7.1%8.2 $1.82
11/15/20227,490,000 shares $14.61 million -5.0%7.6%8.2 $1.95
10/31/20227,880,000 shares $12.77 million -0.5%8.0%8.5 $1.62
10/15/20227,920,000 shares $13.62 million -1.3%8.1%7.8 $1.72
9/30/20228,020,000 shares $17.00 million -14.9%8.1%7 $2.12
9/15/20229,420,000 shares $25.72 million -9.4%9.5%6 $2.73
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)

Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!

Click for Zack's full report
8/31/202210,400,000 shares $22.98 million -7.0%10.5%6.7 $2.21
8/15/202211,180,000 shares $29.29 million -5.4%11.2%7.1 $2.62
7/31/202211,820,000 shares $18.56 million -10.3%11.9%7.5 $1.57
7/15/202213,180,000 shares $22.27 million -26.6%13.3%8.7 $1.69
6/30/202217,950,000 shares $24.05 million -0.8%18.1%12 $1.34
6/15/202218,090,000 shares $23.52 million -1.7%18.2%15.7 $1.30
5/31/202218,400,000 shares $24.66 million -9.8%18.6%13 $1.34
5/15/202220,400,000 shares $27.54 million +3.5%20.7%13.7 $1.35
4/30/202219,710,000 shares $26.21 million +4.4%20.0%12.6 $1.33
4/15/202218,880,000 shares $33.61 million -1.1%19.1%10.7 $1.78
3/31/202219,090,000 shares $40.28 million -15.2%19.4%10.7 $2.11
3/15/202222,520,000 shares $43.69 million -1.1%22.8%12.3 $1.94
2/28/202222,780,000 shares $51.26 million -0.4%23.1%13.9 $2.25
2/15/202222,870,000 shares $50.54 million +26.2%23.1%13.6 $2.21
1/31/202218,120,000 shares $46.75 million +8.7%18.3%11 $2.58
1/15/202216,670,000 shares $53.84 million +9.0%16.8%11 $3.23
12/31/202115,300,000 shares $56.76 million +1.9%15.4%11.2 $3.71
12/15/202115,010,000 shares $56.59 million +1.8%15.1%11.5 $3.77
11/30/202114,750,000 shares $58.12 million +4.2%14.9%12 $3.94
11/15/202114,160,000 shares $56.07 million -4.9%14.1%11.7 $3.96
10/29/202114,890,000 shares $71.92 million -0.6%14.9%13.5 $4.83
10/15/202114,980,000 shares $69.66 million -2.6%15.0%15 $4.65
9/30/202115,380,000 shares $76.75 million -6.3%15.4%15.2 $4.99
9/15/202116,420,000 shares $89.82 million -13.9%16.5%16.4 $5.47
8/31/202119,080,000 shares $115.43 million -3.9%19.3%15.3 $6.05
8/13/202119,860,000 shares $121.94 million -3.1%20.1%17 $6.14
7/30/202120,500,000 shares $112.55 million -1.0%21.0%16.9 $5.49
7/15/202120,710,000 shares $117.43 million -2.4%21.3%16.6 $5.67
6/30/202121,210,000 shares $138.29 million -4.5%21.8%16.6 $6.52
6/15/202122,210,000 shares $149.70 million +0.1%22.9%17.1 $6.74
5/28/202122,180,000 shares $146.39 million -6.4%23.2%18.5 $6.60
5/14/202123,700,000 shares $151.68 million -3.0%25.0%19.4 $6.40
4/30/202124,420,000 shares $200.73 million -5.7%26.1%18.8 $8.22
4/15/202125,890,000 shares $188.22 million -3.9%27.9%15.4 $7.27
3/31/202126,950,000 shares $181.51 million +15.6%29.4%15.8 $6.74
3/15/202123,320,000 shares $208.95 million -2.8%25.9%12.4 $8.96
2/26/202123,980,000 shares $198.79 million -1.3%26.5%13.5 $8.29
2/12/202124,300,000 shares $206.55 million +1.9%27.2%13.7 $8.50
1/29/202123,850,000 shares $201.06 million -1.4%30.3%13.9 $8.43
1/15/202124,180,000 shares $208.19 million No Change34.8%16.2 $8.61

PGEN Short Interest - Frequently Asked Questions

What is Precigen's current short interest?

Short interest is the volume of Precigen shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 15,210,000 shares of PGEN short. 11.81% of Precigen's shares are currently sold short. Learn More on Precigen's current short interest.

What is a good short interest ratio for Precigen?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PGEN shares currently have a short interest ratio of 16.0. Learn More on Precigen's short interest ratio.

What is a good short interest percentage for Precigen?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.81% of Precigen's floating shares are currently sold short.

Is Precigen's short interest increasing or decreasing?

Precigen saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 15,210,000 shares, a decrease of 4.7% from the previous total of 15,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Precigen's float size?

Precigen currently has issued a total of 252,420,000 shares. Some of Precigen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Precigen currently has a public float of 128,830,000 shares.

How does Precigen's short interest compare to its competitors?

11.81% of Precigen's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Precigen: Nanobiotix S.A. (0.12%), Atea Pharmaceuticals, Inc. (2.43%), Verastem, Inc. (3.49%), ADC Therapeutics SA (1.43%), AC Immune SA (0.88%), Kamada Ltd. (0.12%), Nkarta, Inc. (14.02%), Nektar Therapeutics (1.99%), Erasca, Inc. (10.23%), Atai Life Sciences (5.43%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Precigen stock?

Short selling PGEN is an investing strategy that aims to generate trading profit from Precigen as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Precigen?

A short squeeze for Precigen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PGEN, which in turn drives the price of the stock up even further.

How often is Precigen's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PGEN, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:PGEN) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Does this make you sick?
Allegiance Gold
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
The ONE AI Stock to own now. (It’s not Nvidia.)
Weiss Ratings
Urgent Nvidia Warning
Altimetry
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts